1400-61-9

• 常用中文名：制霉菌素
• 常用英文名：Nystatin
• CAS号：1400-61-9
• 分子式：C₄₇H₇₅NO₁₇
• 分子量：276.414
• 相关类别： 原料药 抗生素类药物 多烯类药
• 发布时间：2018-03-23 08:00:00
• 更新时间：2024-01-02 11:53:59
• Nystatin是一种对酵母和支原体有效的多烯抗真菌抗生素。
• 有特殊气味及引湿性菌谱及抗菌机理与两性霉素B相似，主要用于皮肤粘膜、口腔、阴道的白色念珠菌感染.

名称

• 中文名: 制霉菌素
• 英文名: Nystatin
• 中文别名: 制霉素; 米可定,制霉素
• 英文别名: biofanal; 9,11,13,15-Octadecatetraenoic acid; stamycin; MFCD00036240; nystatin A1; Nystex; nilstat; nystatin A2; nystan; MORONAL; EINECS 215-749-0; Nystain; octadeca-9,11,13,15-tetraenoic acid; Nystop; Fungicidin Mycostatin; Nyotran

物化性质

• 密度: 0.9±0.1 g/cm3
• 沸点: 400.2±14.0 °C at 760 mmHg
• 熔点: >155°C (dec.)
• 分子式: C₄₇H₇₅NO₁₇
• 分子量: 276.414
• 闪点: 297.0±15.2 °C
• 精确质量: 276.208923
• PSA: 327.45000
• LogP: 6.14
• 外观性状: 黄色悬浮物
• 蒸汽压: 0.0±2.0 mmHg at 25°C
• 折射率: 1.504
• 储存条件:

  密封、在 -20ºC下保存

• 稳定性:

  如果遵照规格使用和储存则不会分解，未有已知危险反应，避免氧化物

• 分子结构:

  1、 摩尔折射率：240.33

  2、 摩尔体积（m³/mol）：696.1

  3、 等张比容（90.2K）：2018.5

  4、 表面张力（dyne/cm）：70.6

  5、 极化率（10 ^-24cm ³）：95.27

• 计算化学:

  1、 疏水参数计算参考值（XlogP）：-0.2

  2、 氢键供体数量：12

  3、 氢键受体数量：18

  4、 可旋转化学键数量：3

  5、 拓扑分子极性表面积（TPSA）：320

  6、 重原子数量：65

  7、 表面电荷：0

  8、 复杂度：1620

  9、 同位素原子数量：0

  10、 确定原子立构中心数量：10

  11、 不确定原子立构中心数量：9

  12、 确定化学键立构中心数量：6

  13、 不确定化学键立构中心数量：0

  14、 共价键单元数量：1

• 更多:

  1. 性状：悬浮液

  2. 密度（g/mL,25/4℃）： 未确定

  3. 相对蒸汽密度（g/mL,空气=1）：未确定

  4. 熔点（ºC）：未确定

  5. 沸点（ºC,常压）：未确定

  6. 沸点（ºC,5.2kPa）： 未确定

  7. 折射率： 未确定

  8. 闪点（ºC）： 未确定

  9. 比旋光度（º）： 未确定

  10. 自燃点或引燃温度（ºC）： 未确定

  11. 蒸气压（kPa,25ºC）： 未确定

  12. 饱和蒸气压（kPa,60ºC）： 未确定

  13. 燃烧热（KJ/mol）：未确定

  14. 临界温度（ºC）： 未确定

  15. 临界压力（KPa）： 未确定

  16. 油水（辛醇/水）分配系数的对数值： 未确定

  17. 爆炸上限（%,V/V）：未确定

  18. 爆炸下限（%,V/V）： 未确定

  19. 溶解性：不溶于水。

生物活性

• 描述: Nystatin是一种对酵母和支原体有效的多烯抗真菌抗生素。
• 相关类别:
  信号通路 >> 抗感染 >> 真菌
  研究领域 >> 感染
• 体外研究: 制霉菌素导致所有六种念珠菌属物种的颊上皮细胞粘附显着降低[1]。制霉菌素是一种抗生素,可增加质膜对小的单价离子(包括氯离子)的渗透性。制霉菌素增加顶端氯离子渗透性,使得跨上皮细胞氯离子转运受到穿过气管上皮细胞基底外侧膜的转运的限制,这主要反映了协同转运蛋白的活性。制霉菌素(400单位/ mL)使跨上皮36Cl通量的基础水平增加约1.5倍并且消除了该通量的UTP刺激。制霉菌素处理也消除了可饱和的基底外侧[3H]布美他尼结合的UTP刺激,这是这些细胞中功能性Na-K-Cl协同转运蛋白的量度;异戊二烯醇对结合的刺激仅通过制霉菌素治疗轻度抑制[2]。制霉菌素通过主要转换为网格蛋白介导的途径内皮抑素内化,显着增强内皮细胞对内皮抑素的摄取。制霉菌素增强的内皮抑素内化也增加了其对内皮细胞管形成和迁移的抑制作用[3]。
• 体内研究: 制霉菌素与内皮抑素联合使用可选择性地增强肿瘤血管和肿瘤组织中的内皮抑素摄取和生物分布,但不能在荷瘤小鼠的正常组织中增强,最终导致内皮抑素在体内的抗血管生成和抗肿瘤效力提高[3]。脂质体制霉菌素,剂量低至2毫克/千克体重/天,与无治疗,生理盐水或无盐治疗相比,在50天时间点以统计学显着方式保护中性粒细胞减少症小鼠免受曲霉菌诱导的死亡。空脂质体组[4]。
• 参考文献:

  [1]. Ellepola AN, et al. Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin. Oral Microbiol Immunol. 1999 Dec;14(6):358-63.

  [2]. Haas M, et al. Na-K-Cl cotransport in nystatin-treated tracheal cells: regulation by isoproterenol, apical UTP, and [Cl]i. Am J Physiol. 1994 May;266(5 Pt 1):C1440-52.

  [3]. Chen Y, et al. Cholesterol sequestration by nystatin enhances the uptake and activity of endostatin in endothelium via regulating distinct endocytic pathways. Blood. 2011 Jun 9;117(23):6392-403

  [4]. Wallace TL, et al. Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice. Antimicrob Agents Chemother. 1997 Oct;41(10):2238-43

MSDS

Section 1. Chemical Product and Company Identification Nystatin Common Name/ Trade Name Nystatin Section 3. Hazards Identification Potential Acute HealthSlightly hazardous in case of skin contact (irritant), of eye contact (irritant), of ingestion, of inhalation. Effects CARCINOGENIC EFFECTS: Not available. Potential Chronic Health MUTAGENIC EFFECTS: Not available. Effects TERATOGENIC EFFECTS: Not available. DEVELOPMENTAL TOXICITY: Not available. Repeated or prolonged exposure is not known to aggravate medical condition. Section 4. First Aid Measures Eye ContactCheck for and remove any contact lenses. In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Cold water may be used. WARM water MUST be used. Get medical attention if irritation occurs. Skin ContactWash with soap and water. Cover the irritated skin with an emollient. Get medical attention if irritation develops. Serious Skin ContactNot available. InhalationIf inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical attention. Serious InhalationNot available. Do NOT induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to Ingestion an unconscious person. Loosen tight clothing such as a collar, tie, belt or waistband. Get medical attention if symptoms appear. Serious IngestionNot available. Section 5. Fire and Explosion Data Flammability of the Product May be combustible at high temperature. Auto-Ignition Temperature Not available. Flash PointsNot available. Not available. Flammable Limits Not available. Products of Combustion Fire Hazards in Presence of Slightly flammable to flammable in presence of heat. Various Substances Explosion Hazards inRisks of explosion of the product in presence of mechanical impact: Not available. Presence of VariousRisks of explosion of the product in presence of static discharge: Not available. Substances SMALL FIRE: Use DRY chemical powder. Fire Fighting Media LARGE FIRE: Use water spray, fog or foam. Do not use water jet. and Instructions Material in powder form, capable of creating a dust explosion. Special Remarks on Fire Hazards Special Remarks on Explosion Fine dust dispersed in air in sufficient concentrations, and in the presence of an ignition source is a potential dust explosion hazard. Hazards Nystatin Section 6. Accidental Release Measures Small SpillUse appropriate tools to put the spilled solid in a convenient waste disposal container. Finish cleaning by spreading water on the contaminated surface and dispose of according to local and regional authority requirements. Large SpillUse a shovel to put the material into a convenient waste disposal container. Finish cleaning by spreading water on the contaminated surface and allow to evacuate through the sanitary system. Section 7. Handling and Storage Keep away from heat. Keep away from sources of ignition. Ground all equipment containing material. Do Precautions not ingest. Do not breathe dust. If ingested, seek medical advice immediately and show the container or the label. Keep away from incompatibles such as oxidizing agents. StorageKeep container tightly closed. Keep container in a cool, well-ventilated area. Do not store above 8°C (46.4°F). Refrigerate. Moisture sensitive. Sensitive t o light. Store in light-resistant containers. Section 8. Exposure Controls/Personal Protection Engineering ControlsUse process enclosures, local exhaust ventilation, or other engineering controls to keep airborne levels below recommended exposure limits. If user operations generate dust, fume or mist, use ventilation to keep exposure to airborne contaminants below the exposure limit. Personal ProtectionSafety glasses. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. Gloves. Personal Protection in Case of Splash goggles. Full suit. Dust respirator. Boots. Gloves. A self contained breathing apparatus should be a Large Spillused to avoid inhalation of the product. Suggested protective clothing might not be sufficient; consult a specialist BEFORE handling this product. Exposure LimitsNot available. Section 9. Physical and Chemical Properties Physical state and appearance Solid. (Powdered solid.)OdorOdor suggestive of cereal Not available. Taste Not available. Molecular Weight ColorTan. Yellow. (Light.) pH (1% soln/water)Not available. Boiling PointNot available. Melting PointDecomposition temperature: >160°C (320°F) Not available. Critical Temperature Specific GravityNot available. Not applicable. Vapor Pressure Vapor DensityNot available. VolatilityNot available. Odor ThresholdNot available. Water/Oil Dist. Coeff.The product is more soluble in oil; log(oil/water) = 7.1 Not available. Ionicity (in Water) Dispersion PropertiesNot available. Very slightly soluble in cold water. Solubility Insoluble in diethyl ether. Solubility in Water: 360 mg/l at 24 C. Nystatin Section 10. Stability and Reactivity Data The product is stable. Stability Instability TemperatureNot available. Excess heat, incompatible materials, light, moisture, dust generation. Conditions of Instability Incompatibility with various Reactive with oxidizing agents. substances Non-corrosive in presence of glass. Corrosivity Special Remarks onMoisture sensitive Sensitive to light. ReactivityHeat, light and oxygen accelerate decomposition. Special Remarks onNot available. Corrosivity Will not occur. Polymerization Section 11. Toxicological Information Routes of EntryInhalation. Ingestion. Toxicity to AnimalsAcute oral toxicity (LD50): 8000 mg/kg [Mouse]. Chronic Effects on Humans Not available. Other Toxic Effects onSlightly hazardous in case of skin contact (irritant), of ingestion, of inhalation. Humans Special Remarks onNot available. Toxicity to Animals Special Remarks onMay cause adverse reproductive effects and birth defects (teratogenic) based on animal test data. Chronic Effects on Humans May affect genetic material (mutagenic) Special Remarks on otherAcute Potential Health Effects: Toxic Effects on HumansSkin: May cause skin irritation. Eyes: May cause eye irritation. Inhalation: May cause respiratory tract irritation. Ingestion: May cause gastrointestinal tract irritation with nausea, vomiting, diarrhea, and stomach pain. Chronic Potential Health Effects: Ingestion: Prolonged or repeated ingestion may cause weight loss. It may also affect behavior, blood (changes in serum composition), and urinary system (kidneys). Inhalation: Prolonged or repeated inhalation may cause allergic reaction. Skin: Prolonged or repeated skin contact may cause allergic contact dermatitis, although it is rare. Section 12. Ecological Information Not available. Ecotoxicity Not available. BOD5 and COD Products of BiodegradationPossibly hazardous short term degradation products are not likely. However, long term degradation products may arise. Toxicity of the ProductsThe product itself and its products of degradation are not toxic. of Biodegradation Special Remarks on theNot available. Products of Biodegradation Nystatin Section 13. Disposal Considerations Waste DisposalWaste must be disposed of in accordance with federal, state and local environmental control regulations. Section 14. Transport Information DOT ClassificationNot a DOT controlled material (United States). Not applicable. Identification Not applicable. Special Provisions for Transport DOT (Pictograms) Section 15. Other Regulatory Information and Pictograms No products were found. Federal and State Regulations CaliforniaCalifornia prop. 65: This product contains the following ingredients for which the State of California has Proposition 65found to cause cancer which would require a warning under the statute: No products were found. Warnings California prop. 65: This product contains the following ingredients for which the State of California has found to cause birth defects which would require a warning under the statute: No products were found. EINECS: This product is on the European Inventory of Existing Commercial Chemical Substances (EINECS Other Regulations No. 215-749-0). Canada: Listed on Canadian Domestic Substance List (DSL). China: Not listed on National Inventory. Japan: Not listed on National Inventory (ENCS). Korea: Not listed on National Inventory (KECI). Philippines: Not listed on National Inventory (PICCS). Australia: Listed on AICS. WHMIS (Canada) Not controlled under WHMIS (Canada). Other Classifications This product is not classifiedNot applicable. DSCL (EEC) according to the EU regulations. Health Hazard HMIS (U.S.A.)1 National Fire Protection 1 Flammability 1 Association (U.S.A.) Fire Hazard 1 0 Reactivity Health Reactivity 0 Specific hazard Personal Protection E WHMIS (Canada) (Pictograms) DSCL (Europe) (Pictograms) Nystatin TDG (Canada) (Pictograms) ADR (Europe) (Pictograms) Protective Equipment Gloves. Lab coat. Dust respirator. Be sure to use an approved/certified respirator or equivalent. SECTION 16 - ADDITIONAL INFORMATION N/A

毒性和生态

毒理学数据: 急性毒性：大鼠口经LD50：10gm/kg；小鼠口经LD50：8gm/kg；大鼠腹经LD50：24305ug/kg；小鼠腹经LD50：4400ug/kg；小鼠皮下LD50：120mg/kg；小鼠静脉LD50：3mg/kg； 生态学数据: 对是水稍微有危害的不要让未稀释或大量的产品接触地下水、水道或者污水系统，若无政府许可，勿将材料排入周围环境。 CHEMICAL IDENTIFICATION RTECS NUMBER : RF5950000 CHEMICAL NAME : Nystatin CAS REGISTRY NUMBER : 1400-61-9 LAST UPDATED : 199512 DATA ITEMS CITED : 13 MOLECULAR FORMULA : C46-H83-N-O18 MOLECULAR WEIGHT : 938.30 WISWESSER LINE NOTATION : T-38-VO D&V GU IU MU OU QU SUTJ C1 D1 EQ F1 WQ A&VQ B&Q F&Q G&Q J&Q L&Q N&Q UO- BT6OTJ CQ DZ HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 10 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 24305 ug/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 8 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 4400 ug/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 120 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 3 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Mammal - dog DOSE/DURATION : 180 mg/kg/90D-I TOXIC EFFECTS : Kidney, Ureter, Bladder - changes in tubules (including acute renal failure, acute tubular necrosis) Blood - changes in serum composition (e.g. TP, bilirubin, cholesterol) TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Oral DOSE : 100 mg/kg SEX/DURATION : female 9 day(s) after conception TOXIC EFFECTS : Reproductive - Effects on Embryo or Fetus - fetal death MUTATION DATA TEST SYSTEM : Rodent - mouse DOSE/DURATION : 50 mg/kg REFERENCE : EXPEAM Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945- Volume(issue)/page/year: 33,306,1977 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - M1053 No. of Facilities: 28 (estimated) No. of Industries: 1 No. of Occupations: 3 No. of Employees: 8736 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - M1053 No. of Facilities: 372 (estimated) No. of Industries: 1 No. of Occupations: 10 No. of Employees: 25202 (estimated) No. of Female Employees: 22859 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - X9349 No. of Facilities: 3 (estimated) No. of Industries: 1 No. of Occupations: 2 No. of Employees: 2199 (estimated) No. of Female Employees: 2176 (estimated)

安全

• 个人防护装备: Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
• 危害码 (欧洲): F, C
• 风险声明 (欧洲): R11
• 安全声明 (欧洲): S22-S24/25
• 危险品运输编码: NONH for all modes of transport
• WGK德国: 3
• RTECS号: RF5950000
• 海关编码: 2942000000

海关

海关编码	2942000000